RetroSearch Browse

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/23697514/ below:

Results of initial low-dose computed tomographic screening for lung cancer

Randomized Controlled Trial

. 2013 May 23;368(21):1980-91. doi: 10.1056/NEJMoa1209120. Results of initial low-dose computed tomographic screening for lung cancer Timothy R Church, William C Black, Denise R Aberle, Christine D Berg, Kathy L Clingan, Fenghai Duan, Richard M Fagerstrom, Ilana F Gareen, David S Gierada, Gordon C Jones, Irene Mahon, Pamela M Marcus, JoRean D Sicks, Amanda Jain, Sarah Baum

Collaborators

National Lung Screening Trial Research Team: Timothy R Church, William C Black, Denise R Aberle, Christine D Berg, Kathy L Clingan, Fenghai Duan, Richard M Fagerstrom, Ilana F Gareen, David S Gierada, Gordon C Jones, Irene Mahon, Pamela M Marcus, JoRean D Sicks, Amanda Jain, Sarah Baum, Edward A Sausville, Wylie Burke, Gene Colice, Brenda Edwards, Scott Emerson, Russell Harris, David Johnstone, Jeffrey S Klein, Edward L Korn, Robert Mayer, Joe V Selby, David W Sturges, Bruce W Turnbull, Thomas J Watson, John Fletcher, Sylvan Green, Anthony B Miller, Martin J Edelman, William K Evans, Robert S Fontana, Mitchell Machtay, Robert C Young, David Alberts, David DeMets, Peter Greenwald, Paula Jacobs, Theresa C McLoud, David P Naidich, James Tatum

PMID: 23697514
PMCID: PMC3762603
DOI: 10.1056/NEJMoa1209120

Item in Clipboard

Randomized Controlled Trial

Results of initial low-dose computed tomographic screening for lung cancer

National Lung Screening Trial Research Team et al. N Engl J Med. 2013.

. 2013 May 23;368(21):1980-91. doi: 10.1056/NEJMoa1209120. Authors National Lung Screening Trial Research Team; Timothy R Church, William C Black, Denise R Aberle, Christine D Berg, Kathy L Clingan, Fenghai Duan, Richard M Fagerstrom, Ilana F Gareen, David S Gierada, Gordon C Jones, Irene Mahon, Pamela M Marcus, JoRean D Sicks, Amanda Jain, Sarah Baum Collaborators

National Lung Screening Trial Research Team: Timothy R Church, William C Black, Denise R Aberle, Christine D Berg, Kathy L Clingan, Fenghai Duan, Richard M Fagerstrom, Ilana F Gareen, David S Gierada, Gordon C Jones, Irene Mahon, Pamela M Marcus, JoRean D Sicks, Amanda Jain, Sarah Baum, Edward A Sausville, Wylie Burke, Gene Colice, Brenda Edwards, Scott Emerson, Russell Harris, David Johnstone, Jeffrey S Klein, Edward L Korn, Robert Mayer, Joe V Selby, David W Sturges, Bruce W Turnbull, Thomas J Watson, John Fletcher, Sylvan Green, Anthony B Miller, Martin J Edelman, William K Evans, Robert S Fontana, Mitchell Machtay, Robert C Young, David Alberts, David DeMets, Peter Greenwald, Paula Jacobs, Theresa C McLoud, David P Naidich, James Tatum

PMID: 23697514
PMCID: PMC3762603
DOI: 10.1056/NEJMoa1209120

Item in Clipboard

Abstract

Background: Lung cancer is the largest contributor to mortality from cancer. The National Lung Screening Trial (NLST) showed that screening with low-dose helical computed tomography (CT) rather than with chest radiography reduced mortality from lung cancer. We describe the screening, diagnosis, and limited treatment results from the initial round of screening in the NLST to inform and improve lung-cancer-screening programs.

Methods: At 33 U.S. centers, from August 2002 through April 2004, we enrolled asymptomatic participants, 55 to 74 years of age, with a history of at least 30 pack-years of smoking. The participants were randomly assigned to undergo annual screening, with the use of either low-dose CT or chest radiography, for 3 years. Nodules or other suspicious findings were classified as positive results. This article reports findings from the initial screening examination.

Results: A total of 53,439 eligible participants were randomly assigned to a study group (26,715 to low-dose CT and 26,724 to chest radiography); 26,309 participants (98.5%) and 26,035 (97.4%), respectively, underwent screening. A total of 7191 participants (27.3%) in the low-dose CT group and 2387 (9.2%) in the radiography group had a positive screening result; in the respective groups, 6369 participants (90.4%) and 2176 (92.7%) had at least one follow-up diagnostic procedure, including imaging in 5717 (81.1%) and 2010 (85.6%) and surgery in 297 (4.2%) and 121 (5.2%). Lung cancer was diagnosed in 292 participants (1.1%) in the low-dose CT group versus 190 (0.7%) in the radiography group (stage 1 in 158 vs. 70 participants and stage IIB to IV in 120 vs. 112). Sensitivity and specificity were 93.8% and 73.4% for low-dose CT and 73.5% and 91.3% for chest radiography, respectively.

Conclusions: The NLST initial screening results are consistent with the existing literature on screening by means of low-dose CT and chest radiography, suggesting that a reduction in mortality from lung cancer is achievable at U.S. screening centers that have staff experienced in chest CT. (Funded by the National Cancer Institute; NLST ClinicalTrials.gov number, NCT00047385.).

PubMed Disclaimer

Figures
Figure 1. Enrollment and Follow-up of the…

Figure 1. Enrollment and Follow-up of the Study Participants after the Initial Screening

A total…

Figure 1. Enrollment and Follow-up of the Study Participants after the Initial Screening

A total of 490 lung cancers were diagnosed: 406 in participants with positive screening results (270 in the low-dose computed tomography [CT] group and 136 in the radiography group), 67 in participants with negative results (18 and 49, respectively), and 9 in participants who missed the screening (4 and 5, respectively), as well as an additional 8 cancers in participants who were ineligible for the initial screening but received a diagnosis of lung cancer during the screening period (5 and 3, respectively). If an inadequate examination was performed (e.g., because of its quality, the image was not interpretable) and no rescreening took place, the participant was considered not to have been screened.